FDA Approved: OCTREOTIDE — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for octreotide acetate filed by Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Carcinoid Syndrome
• Carcinoid Tumor
• Esophageal Variceal Bleeding
• Gastroenteropancreatic Neuroendocrine Tumor
• Pancreatic Neuroendocrine Tumor
• Vipoma

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

SUPPL AP for OCTREOTIDE (OCTREOTIDE ACETATE)